The financial opportunity within the DNA encoded library market has been analyzed across the following segments:
- Application Area
- Hit Generation / Identification
- Hit to Lead
- Hit Validation / Optimization
- Other Application Areas
- Therapeutic Area
- Oncological Disorders
- Immunological Disorders
- Neurological Disorders
- Respiratory Disorders
- Dermatological Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Other Therapeutic Areas
- End-user
- Pharma / Biopharma Industry
- Academic / Research Institute
- Other End-users
- Type of Payment Model Employed
- Upfront Payment
- Milestone Payment
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
The research also includes detailed profiles of key players (listed below) offering DNA encoded library platforms and services; each profile features a brief overview of the company, its financial information (if available), details on platform and service portfolio, recent developments and an informed future outlook.
- AlphaMa
- DICE Therapeutics
- DyNAbind
- HitGen
- NovAliX
- Vipergen
- WuXi AppTec
- X-Chem
Table of Contents
- Preface
2. Executive Summary
Introduction
- Market Landscape
- Business Model Analysis
- Company Competitiveness Analysis
- Company Profiles
- Partnerships and Collaborations
- Global Event Analysis
- Patent Analysis
- Big Pharma Initiatives
- Case Study: Companies / Organizations Supporting the Development of DNA Encoded
Libraries
- Market Forecast and Opportunity Analysis
- Concluding Remarks
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/dna-encoded-libraries/288.html
Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
